Biotechnology Research, Medical and pharmaceutical research, Research and testing · 2 Employees
Email Address: francois.cavalie@skindermic.com
Overview
Employees
Access 6 Verified Employees Profiles for SkindermicUnlock Free Contacts Now
About
SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases.
SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas).
Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris.